Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibody Response After SARS-CoV-2 Infection and Implications for Immunity
Irina Arkhipova-Jenkins, Mark Helfand, Charlotte Armstrong, et al.
Annals of Internal Medicine (2021) Vol. 174, Iss. 6, pp. 811-821
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 375
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Therapeutic Advances in Neurological Disorders (2021) Vol. 14
Open Access | Times Cited: 344
SARS-CoV-2 Variants, Vaccines, and Host Immunity
Priyal Mistry, Fatima Barmania, Juanita Mellet, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 275
Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time
A. Sarah Walker, Emma Pritchard, Thomas House, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 109
Utility of Different Surrogate Enzyme-Linked Immunosorbent Assays (sELISAs) for Detection of SARS-CoV-2 Neutralizing Antibodies
Niko Kohmer, Cornelia Rühl, Sandra Ciesek, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 10, pp. 2128-2128
Open Access | Times Cited: 60
Risk for Reinfection After SARS-CoV-2: A Living, Rapid Review for American College of Physicians Practice Points on the Role of the Antibody Response in Conferring Immunity Following SARS-CoV-2 Infection
Mark Helfand, Celia Fiordalisi, Jack Wiedrick, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 4, pp. 547-555
Open Access | Times Cited: 49
The mystery of COVID-19 reinfections: A global systematic review and meta-analysis
Rubaid Azhar Dhillon, Mohammad Aadil Qamar, Jaleed Ahmed Gilani, et al.
Annals of Medicine and Surgery (2021) Vol. 72, pp. 103130-103130
Open Access | Times Cited: 40
Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses
Ron Milo, Elsebeth Staun-Ram, Dimitrios Karussis, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Factors associated with anti-SARS-CoV-2 antibody titres 3 months post-vaccination with the second dose of BNT162b2 vaccine: a longitudinal observational cohort study in western Greece
Anastasia Parthymou, Evagelia E Habeos, George I. Habeos, et al.
BMJ Open (2022) Vol. 12, Iss. 5, pp. e057084-e057084
Open Access | Times Cited: 35
Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Sudeb C. Dalai, Jennifer N. Dines, Thomas M. Snyder, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 12, pp. 2079-2087
Open Access | Times Cited: 33
Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study
Maala Bhatt, Amy C. Plint, Ken Tang, et al.
CMAJ Open (2022) Vol. 10, Iss. 2, pp. E357-E366
Open Access | Times Cited: 28
Testing for SARS-CoV-2: lessons learned and current use cases
Elitza S. Theel, James E. Kirby, Nira R. Pollock
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 5
SARS-CoV-2 evolution on a dynamic immune landscape
N. Alexia Raharinirina, Nils Gubela, Daniela Börnigen, et al.
Nature (2025)
Open Access
SARS-CoV-2 seroprevalence and associated risk factors in adult outpatients from Western Romania, January to March 2023: a seroepidemiological assessment after three years of COVID-19 pandemic
Tudor Rareș Olariu, Sorin Ursoniu, Alina Cristiana Craciun, et al.
Infectious Diseases (2025), pp. 1-11
Open Access
Explaining Racial and Ethnic Inequities in SARS-CoV-2-Related Outcomes: Results from a Serosurvey in Chicago
Catherine Eyo, Joshua M. Schrock, Christina Hayford, et al.
Journal of Racial and Ethnic Health Disparities (2025)
Closed Access
SARS-CoV-2–specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies
Anna Jeffery-Smith, Alice R. Burton, Sabela Lens, et al.
Journal of Clinical Investigation (2021) Vol. 132, Iss. 2
Open Access | Times Cited: 35
COVID-19 reinfection: the role of natural immunity, vaccines, and variants
Bao Y. Sciscent, Caroline Eisele, Lisa Ho, et al.
Journal of Community Hospital Internal Medicine Perspectives (2021) Vol. 11, Iss. 6, pp. 733-739
Open Access | Times Cited: 33
Infants and young children generate more durable antibody responses to SARS-CoV-2 infection than adults
Devyani Joshi, Lindsay E. Nyhoff, Veronika I. Zarnitsyna, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107967-107967
Open Access | Times Cited: 12
Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time
A. Sarah Walker, Emma Pritchard, Thomas House, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 33
kinetics of anti-SARS-CoV-2 antibodies over time. Results of 10 month follow up in over 300 seropositive Health Care Workers
José F. Varona, Rodrigo Madurga, Francisco Peñalver, et al.
European Journal of Internal Medicine (2021) Vol. 89, pp. 97-103
Open Access | Times Cited: 29
The IgA in milk induced by SARS-CoV-2 infection is comprised of mainly secretory antibody that is neutralizing and highly durable over time
Alisa Fox, Jessica Marino, Fatima Amanat, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0249723-e0249723
Open Access | Times Cited: 21
Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort–EPICOV
Josiane Warszawski, Laurence Meyer, Jeanna-Eve Franck, et al.
PLoS ONE (2022) Vol. 17, Iss. 5, pp. e0267725-e0267725
Open Access | Times Cited: 20
Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection
Kimia Sobhani, Susan Cheng, Raquel A. Binder, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1644-1644
Open Access | Times Cited: 11
Laboratory medicine in the COVID-19 era: six lessons for the future
Mario Plebani
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 6, pp. 1035-1045
Open Access | Times Cited: 24
Improvements and limits of anti SARS-CoV-2 antibodies assays by WHO (NIBSC 20/136) standardization
Davide Giavarina, Mariarosa Carta
Diagnosis (2021) Vol. 9, Iss. 2, pp. 274-279
Closed Access | Times Cited: 24
Page 1 - Next Page

Scroll to top